Related Experiment Video
Updated: Aug 5, 2026
12:20
Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Encephalitic Alphaviruses: Epidemiology, Pathogenesis and Vaccine Development
Nouha Kisra1, Zoe de Zeeuw2, George Eustace3
1St Hilda's College, University of Oxford, Cowley Place, Oxford OX4 1DY, UK.
Vaccines
|July 27, 2026
Summary
New vaccines are needed for Eastern, Venezuelan, and Western equine encephalitis viruses (EEEV, VEEV, WEEV) due to climate change. Novel platforms like mRNA show promise for developing safe and effective EEEV, VEEV, and WEEV vaccines.
Area of Science:
- Virology
- Public Health
- Vaccinology
Background:
- Eastern, Venezuelan, and Western equine encephalitis viruses (EEEV, VEEV, WEEV) are mosquito-borne alphaviruses causing severe neurological disease in the Americas.
- Human infections can range from mild febrile illness to life-threatening encephalitis.
- Current vaccine options are limited to superseded formulations, necessitating updated public health strategies.
Purpose of the Study:
- To review recent advancements in understanding EEEV, VEEV, and WEEV pathogenesis and transmission.
- To summarize current diagnostic and treatment management strategies.
- To highlight recent progress in vaccine development for these equine encephalitis viruses.
Main Methods:
- Literature review of recent scientific publications on EEEV, VEEV, and WEEV.
- Analysis of pre-clinical and clinical trial data for novel vaccine candidates.
- Synthesis of information on viral spread, disease mechanisms, and therapeutic interventions.
Main Results:
- Recent research has deepened the understanding of EEEV, VEEV, and WEEV epidemiology and disease progression.
- Novel vaccine platforms, including mRNA and viral vectors, are showing significant promise in pre-clinical and clinical studies.
- Improved diagnostic and treatment protocols are emerging, though not yet widely available.
Conclusions:
- There is an urgent need for safe and effective vaccines against EEEV, VEEV, and WEEV, driven by factors including climate change and ecological disruption.
- Novel vaccine technologies offer a viable path towards achieving broad public access to protection against these dangerous viruses.
- Continued research and development are crucial for controlling outbreaks and mitigating the impact of equine encephalitis viruses.
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:25Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...